openPR Logo
Press release

Lung Cancer Diagnostics KRAS Mutation Tests Market to Register an Impressive 7.3% CAGR During the Forecast Period 2017 to 2022

05-24-2021 12:44 PM CET | Health & Medicine

Press release from: Fact.MR

According to a recent report by Fact.MR, the global lung cancer diagnostics market is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Click HERE to Get Complete Synopsis of the Report- https://www.factmr.com/report/49/lung-cancer-diagnostics-market

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies. Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Key market players included in Fact.MR’s reports are

Illumina, Inc.

Thermo Fischer Scientific, Inc.

Quest Diagnostics Incorporated

NanoString Technologies, Inc.

Myriad Genetics, Inc.

Roche Holding AG

Abbott Laboratories

QIAGEN N.V.

NeoGenomics Laboratories

Danaher Corporation.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Several awareness programs related to lung cancer and its symptoms are being taken by the private as well as government authorities for enhancing the diagnosis as well as screening rates of patients with high risks of lung malignancies. In the United Kingdom, November has been considered as lung cancer awareness month, and Roy Castle Lung Cancer Foundation has been supporting the initiative. These kinds of initiatives will fuel demand for diagnosis of lung cancer, which in turn will propel growth of the market.

Market Taxonomy

By Test Type

CA Test

HER2 Tests

ALK Tests

Angiogenesis Inhibitor

EGFR Mutation Tests

KRAS Mutation Tests

For More Insights: https://www.biospace.com/article/increasing-spending-on-cancer-treatment-research-is-driving-growth-of-early-stage-lung-cancer-diagnostics-market-notes-fact-mr

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Cancer Research Institutes

By Indication

Non Small-cell Lung Cancer

Small-cell Lung Cancer

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/49/S

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.

Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.

CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.

Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.

Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.

Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.

Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=49

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Diagnostics KRAS Mutation Tests Market to Register an Impressive 7.3% CAGR During the Forecast Period 2017 to 2022 here

News-ID: 2289143 • Views:

More Releases from Fact.MR

Gear Measuring Machines Market Forecasted to Expand at 3.1% CAGR, Reaching $499.7 Million by 2032
Gear Measuring Machines Market Forecasted to Expand at 3.1% CAGR, Reaching $499. …
The major reasons propelling the gear measuring markets are the growing output of automobiles and manufacturing, the notable acceleration of economic growth, and the paradigm change towards more energy-efficient products. By the end of 2032, the size of the global gear measuring machines market is expected to reach US$ 499.7 million, growing at a CAGR of 3.1%. The gear measuring devices are equipped with a range of software packages, the price
Metal Cleaning Chemicals Market to Grow at 3.5% CAGR, Reaching USD 18.9 Billion by 2032
Metal Cleaning Chemicals Market to Grow at 3.5% CAGR, Reaching USD 18.9 Billion …
According to projections, the global metal cleaning chemicals market will surpass US$ 18.9 billion by 2032, expanding at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2032. The need for maintenance on heavy machinery and equipment has increased due to the manufacturing sector's global expansion. Therefore, the need for metal cleaning chemicals to preserve operating efficiency is probably going to drive the market. Conventional metal cleaning solutions are
Dermatology CRO Market to Grow at 9.1% CAGR, Valued at $12.8 Billion by 2032
07-16-2024 | Health & Medicine
Fact.MR
Dermatology CRO Market to Grow at 9.1% CAGR, Valued at $12.8 Billion by 2032
The dermatology CRO market is expected to generate revenues of US$ 4 billion in 2021 and rise at a compound annual growth rate (CAGR) of 9.1% from 2022 to 2032. The market is anticipated to reach US$ 12.8 billion by the end of 2032. Dermatology CRO revenue is predicted to rise at the quickest rate in North America between 2022 and 2032, with a projected growth rate of around 10.4%. The
Belt Loaders Market to Experience Steady Growth, Surpassing $1,635 Million by 2032
Belt Loaders Market to Experience Steady Growth, Surpassing $1,635 Million by 20 …
The global belt loaders market, valued at USD 1,125 million in 2022, is projected to exceed USD 1,635 million by 2032, experiencing a growth rate of 3.8% CAGR over the period from 2022 to 2032. The belt loaders market has emerged as a critical segment within the ground support equipment (GSE) industry, playing a vital role in the efficient handling of cargo and baggage at airports worldwide. Belt loaders, designed to

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top